Clinical trial
A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001
NCT00382408 · Duramed Research, Industry · Completed
Key facts
| NCT number | NCT00382408 |
|---|---|
| Title | A Clinical Trial to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001 |
| Official title | A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Efficacy, and Immunogenicity of DR-5001 |
| Lead sponsor | Duramed Research, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Respiratory Tract Diseases |
| Intervention type | Biological, Other |
| Interventions | DR-5001, Placebo |
| Enrollment | 4,040 |
| Start date | Sep 1, 2006 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Sep 29, 2006 |
| Last update posted | Apr 10, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: